Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_assertion type Assertion NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_head.
- NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_assertion description "[Following confirmation of the natural history of this leukemia in the transgenic mice, we demonstrated that the transformed murine lymphocytes express relevant therapeutic targets (Bcl-2, Mcl-1, AKT, PDK1, and DNMT1), wild-type p53 status, and in vitro sensitivity to therapeutic agents relevant to the treatment of human CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_provenance.
- NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_assertion evidence source_evidence_literature NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_provenance.
- NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_assertion SIO_000772 16670263 NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_provenance.
- NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_assertion wasDerivedFrom befree-2016 NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_provenance.
- NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_assertion wasGeneratedBy ECO_0000203 NP547990.RAowIbiaTOWTEy7EUC8rMdTi9lHsPk7oY0_TTdE5XsB4o130_provenance.